- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/335 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Lactobacillus (G)
Patent holdings for IPC class C07K 14/335
Total number of patents in this class: 173
10-year publication summary
|
6
|
5
|
13
|
13
|
16
|
10
|
14
|
21
|
11
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| University of Florida Research Foundation, Inc. | 4016 |
8 |
| Quorum Innovations, LLC | 34 |
7 |
| Microsintesis Inc. | 12 |
6 |
| Sumitomo Chemical Company, Limited | 9046 |
4 |
| Cell Biotech Co., Ltd. | 57 |
4 |
| Intrexon ActoBiotics NV | 45 |
4 |
| Meiji Co., Ltd. | 721 |
4 |
| Centre National de La Recherche Scientifique | 10418 |
3 |
| BioGaia AB | 198 |
3 |
| The University of British Columbia | 1497 |
3 |
| Chr. Hansen A/S | 1059 |
3 |
| Agrospheres, Inc. | 39 |
3 |
| RISE Therapeutics LLC | 3 |
3 |
| Shanghai Longxin Biomedical Technology Co., Ltd | 6 |
3 |
| Massachusetts Institute of Technology | 10041 |
2 |
| Wisconsin Alumni Research Foundation | 3874 |
2 |
| The General Hospital Corporation | 4724 |
2 |
| Novozymes A/S | 3318 |
2 |
| Agency for Science, Technology and Research | 3610 |
2 |
| Bioneer Corporation | 239 |
2 |
| Other owners | 103 |